Ebola vaccine performs well in U.K. human trial
An experimental vaccine against Ebola is relatively safe in humans, a U.K.-based study of 60 people finds. A trial of another vaccine (shown being administered above) produced similar results in 20 patients in a National Institutes of Health study in September.
NIAID (CC BY 2.0)
This article is only available to Science News subscribers.
Subscribers, enter your e-mail address to access our archives.
